Results 151 to 160 of about 21,293 (203)

Comparative effectiveness and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in patients with HBV-associated decompensated cirrhosis: insights from a retrospective analysis. [PDF]

BMC Infect Dis
Chen L, Zhang HF, Cai YJ, Zhang L, Cai C, Lu MQ, Zhu YY.   +6 more
europepmc   +1 more source

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]

Open Forum Infect Dis
Li A, Li Z, Li J, Gao Y, Dai L, Liu A, Zhang H, Wang X, Wu L, Yao Y, Liu L, Ye J, Sun L.   +12 more
europepmc   +1 more source

Efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in HIV treatment: a real-world single-center study in China. [PDF]

Front Med (Lausanne)
Li A, Liu L, Zhang H, Wang X, Li Z, Liu A, Dai L, Zhang J, Gao Y, Ye J, Li J, Sun L.   +11 more
europepmc   +1 more source

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment. [PDF]

Aliment Pharmacol Ther
Wong GL, Gane E, Pan CQ, Fung S, Ma MM, Izumi N, Shalimar, Lim SG, Chuang WL, Mehta R, Lim YS, Yee LJ, Flaherty JF, Abramov F, Wang H, Buti M.   +15 more
europepmc   +1 more source

Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial. [PDF]

Clin Mol Hepatol
Yim HJ, Seo YS, Kim JH, Kim W, Jung YK, Jang JY, Lee SH, Kim YS, Kim CW, Kim HS, Shim JJ, Cho EY, Kim IH, Lee BS, Lee JH, Kim BS, Jang JW, Lee HW, Kwon JH, Kim MY, Song DS, Park JG, Lee YS, Yoon EL, Lee HA, Kang SH, Yang JM.   +26 more
europepmc   +1 more source

Effect of weight gain on blood pressure in Ugandan persons with HIV on dolutegravir/lamivudine/ tenofovir disoproxil fumarate over 48 weeks. [PDF]

PLoS One
Amutuhaire W, Castelnuovo B, Brusselaers N, Nabwana M, Muhammad L, Maloney B, Nixon B, Schwarz JM, Mulindwa F.   +8 more
europepmc   +1 more source

Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy. [PDF]

PLoS One
Lin Y, Lin X, Xia R, Chen J, Lin Z, Lu S.   +5 more
europepmc   +1 more source

Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study. [PDF]

BMC Pregnancy Childbirth
Li S, Jiang Y, Shi J, Jiang X, Li Y, Ma Z, Jin J.   +6 more
europepmc   +1 more source

Cost-effectiveness of tenofovir disoproxil fumarate prophylaxis for perinatal hepatitis B virus prevention in Ethiopia: a decision analytical modeling. [PDF]

BMC Public Health
Negasa AG, Bobo FT, Falta DF, Chala TK, Bayou NB.   +4 more
europepmc   +1 more source

A comparison of the therapeutic efficacy of Tenofovir Disoproxil Fumarate and Entecavir in patients with chronic Hepatitis-B. [PDF]

Pak J Med Sci
Wang H, Wu L.
europepmc   +1 more source